Frew Emma
Health Economics Unit, University of Birmingham, Birmingham, UK.
Pharmacoeconomics. 2016 Aug;34(8):733-40. doi: 10.1007/s40273-016-0398-8.
Rising levels of childhood obesity present a serious global public health problem amounting to 7 % of GDP in developed countries and affecting 14 % of children. As such, many countries are investing increasingly large quantities of resource towards treatment and prevention. Whilst it is important to demonstrate the clinical effectiveness of any intervention, it is equally as important to demonstrate cost effectiveness as policy makers strive to get the best value for money from increasingly limited public resources. Economic evaluation assists with making these investment decisions and whilst it can offer considerable support in many healthcare contexts, applying it to a childhood obesity context is not straightforward. Childhood obesity is a complex disease with interventions being multi-component in nature. Furthermore, the interventions are implemented in a variety of settings such as schools, the community, and the home, and have costs and benefits that fall outside the health sector. This paper provides a reflection from a UK perspective on the application of the conventional approach to economic evaluation to childhood obesity. It offers suggestions for how evaluations should be designed to fit better within this context, and to meet the needs of local decision makers. An excellent example is the need to report costs using a micro-costing format and for benefit measurement to go beyond a health focus. This is critical as the organisation and commissioning of childhood obesity services is done from a Local Authority setting and this presents further challenges for what is the most appropriate economic evaluation approach to use. Given that adult obesity is now of epidemic proportions, the accurate assessment of childhood obesity interventions to support public health decision making is critical.
儿童肥胖率的不断上升成为一个严重的全球公共卫生问题,在发达国家占国内生产总值的7%,影响着14%的儿童。因此,许多国家正投入越来越多的资源用于治疗和预防。虽然证明任何干预措施的临床有效性很重要,但证明成本效益同样重要,因为政策制定者努力从日益有限的公共资源中获得最大价值。经济评估有助于做出这些投资决策,虽然它在许多医疗环境中能提供相当大的支持,但将其应用于儿童肥胖情况并非易事。儿童肥胖是一种复杂疾病,干预措施本质上是多方面的。此外,这些干预措施在学校、社区和家庭等各种环境中实施,其成本和效益超出了卫生部门的范畴。本文从英国的视角反思了传统经济评估方法在儿童肥胖问题上的应用。它就如何设计评估以更好地适应这一情况并满足当地决策者的需求提出了建议。一个很好的例子是需要使用微观成本核算格式报告成本,并且效益衡量要超越对健康的关注。这至关重要,因为儿童肥胖服务的组织和委托是在地方当局的框架下进行的,这就对采用何种最合适的经济评估方法提出了进一步挑战。鉴于成人肥胖现已达到流行程度,准确评估儿童肥胖干预措施以支持公共卫生决策至关重要。